Background This study aims to determine whether the quantification of myocardial fibrosis in
patients with Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a late …

Purpose To evaluate the potential of non-contrast myocardial T1 mapping on cardiovascular
magnetic resonance examination (CMR) in differentiating patients with Fabry disease (FD) …

Background—Fabry disease (FD) is an X-linked disorder of lysosomal metabolism affecting
multiple organs with cardiac disease being the leading cause of death. Current imaging …

Background Cardiac involvement is common and is the leading cause of mortality in Fabry
disease (FD). We explored the association between cardiovascular magnetic resonance …

Fabry disease (FD) causes myocardial native T1 lowering on cardiac magnetic resonance
(CMR), left ventricular hypertrophy (LVH), and late gadolinium enhancement (LGE). LVH is …

Background Fabry disease is one of the causes of left ventricular hypertrophy (LVH) and can
be treated with enzyme replacement therapy or pharmacological chaperone therapy. Late …

Background Cardiac involvement is the leading cause of mortality in patients with Fabry
disease. Identification of imaging findings that predict adverse cardiac events is needed to …

Background Cardiac involvement is a major contributor of morbidity and mortality in Fabry
disease (FD). Early detection and accurate evaluation of the disease progression is …

Aims This cross-sectional study aimed to analyse myocardial deformation in patients with
Fabry disease (FD) in order to evaluate speckle tracking as a method for non-invasive …

Abstract Introduction About 50% of Fabry disease (FD) patients develop cardiac
manifestation, also known as Fabry cardiomyopathy. Beside echocardiography, cardiac …